The U.S. Food and Drug Administration approved clinical testing for an Ebola treatment this week. This new treatment is produced by Aethlon Medical Inc., a San-Diego based company. The treatment, called Aethlon’s Hemopurifier blood filter has been approved for patients infected with Ebola that are inside the United States.
This is not a drug but a bio-filtration gadget created for a one- time-use treatment to expel infections found within the blood system like the lethal and easily contagious Ebola virus. The medical device particularly focuses on any antiviral medication resistance of the virus. This type of treatment aims to serve as a basic countermeasure to Ebola (and different infections) which can’t be tackled with current medication treatments.
The endorsement of this Ebola treatment will permit research to be conducted in 10 areas and 20 subjects nationwide. Every selected patient will get a Hemopurifier daily administration. The devices will be used from six to eight hours until the Ebola viral load goes under 1,000 duplicates every blood ml.
Of course, the objective of the study is to establish a standard practice and assess how to successfully and effectively utilize the item to treat Ebola worldwide.
According to Aethlon reports, the Hemopurifier treatment was successful when a patient in a Critical Ebola condition received the treatment in Frankfurt University Hospital in Germany. The virus duplicates per mL of blood with the given patient were of 400,000. After being administered a 6.5-hour treatment the Ebola virus duplicates drastically tumbled to 1,000 per mL of blood.
At the time Aethlon started its treatment, the patient was not conscious and was struggling with multiple organ failure, being on the verge of dying. After the treatment his condition improved significantly. Slowly the patient was completely recovered and was able to return home to his family.
The present Ebola outbreak is considered the most severe on record and killed no less than 7,905 lives until now. The most common symptoms displayed by Ebola Virus carriers are fever, strong headaches, muscle distress, diarrhea, stomachache and external bleeding, as indicated by U.S. Centers for Disease Control and Prevention (CDC).
Ebola is contagious if healthy people come in contact with bodily fluids of the infected including “urine, saliva, sweat, feces, vomit, breast milk, and semen”, as per the CDC. Also, contact with tainted syringes or fruit bats and primates can prompt the spread of the ailment.
The device is also being tested in India to examine if it can speed up the viral load reduction when combined with a hepatitis C treatment.
Image Source: Times of San Diego